Senti Biosciences's total assets for Q3 2024 were $57.72M, a decrease of -33.59% from the previous quarter. SNTI total liabilities were $41.73M for the fiscal quarter, a -2.43% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.